This trial is conducted in Europe. The aim of this trial is to describe the safety and tolerability of single intravenous (i.v.) and subcutaneous (s.c.) doses of NNC0215-0384 in subjects with active rheumatoid arthritis (RA) on background methotrexate (MTX) treatment.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01611688?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30
